Adjuvant treatment for endometrial cancer: Literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO)

Autor: Mélanie Morneau, William Foster, Marc Lalancette, Thu Van Nguyen-Huynh, Marie-Claude Renaud, Vanessa Samouëlian, Nathalie Letarte, Karine Almanric, Gino Boily, Philippe Bouchard, Jim Boulanger, Ghislain Cournoyer, Félix Couture, Normand Gervais, Stéphanie Goulet, Marie-Pascale Guay, Mélanie Kavanagh, Julie Lemieux, Bernard Lespérance, Jean-François Ouellet, Gilles Pineau, Raghu Rajan, Isabelle Roy, Benoît Samson, Lucas Sidéris, François Vincent

Publikováno v: Gynecologic Oncology. 131:231-240

Objective Despite the very good prognosis of endometrial cancer, a number of patients with localized disease relapse following surgery. Therefore, various adjuvant therapeutic approaches have been studied. The objective of this review is to evaluate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f7394aadee00f6f17f82aef0e2d67d
https://doi.org/10.1016/j.ygyno.2013.07.084

Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non-Small-Cell Lung Cancer: CEPO Review and Recommendations.

Autor: Boily G; Institut national d'excellence en santé et en service sociaux (INESSS), Québec; †Hôpital Notre-Dame (CHUM), Montréal; ‡Hôpital Maisonneuve-Rosemont, Montréal; §Montreal General Hospital (MUHC), Montréal; ‖Institut universitaire de cardiologie et de pneumologie de Québec, Québec; ¶Hôpital Charles-LeMoyne (CSSS Champlain-Charles-LeMoyne), Greenfield Park; #Hôpital de la Cité-de-la-Santé (CSSS de Laval), Laval, Québec, Canda; and **The Comité de l'évolution des pratiques en oncologie (CEPO), a group of specialists in oncology that reports to the INESSS. Its role is to provide physicians and other health professionals in the field of oncology with evidence-based guidelines and clinical support tools to optimize and standardize clinical practice in the province of Québec, Canada. The CEPO's members are Karine Almanric, BPharm, MSc, BCOP, Hôpital de la Cité-de-la-Santé (CSSS de Laval); Jean-Sébastien Aucoin, MD, Centre hospitalier affilié universitaire régional (CSSS de Trois-Rivières); Gino Boily, PhD, INESSS; Philippe Bouchard BPharm, MSc, BCOP, Hôpital Maisonneuve-Rosemont; Jim Boulanger, PhD, INESSS; Alexis Bujold, MD, Hôpital Maisonneuve-Rosemont; Ghislain Cournoyer, MD, Hôpital régional de Saint-Jérôme (CSSS de Saint-Jérôme); Félix Couture, MD, Hôtel-Dieu de Québec (CHU de Québec); Normand Gervais, MD, Centre hospitalier régional du Grand-Portage (CSSS de Rivière-du-Loup); Stéphanie Goulet, PhD, INESSS; Marie-Pascale Guay, BPharm, MSc, BCOP, Jewish General Hospital (MUHC); Bernard Lespérance, MD, Hôpital du Sacré-Cœur de Montréal, Groupe d'étude en oncologie du Québec; Nathalie Letarte, BPharm, MSc, BCOP, Hôpital Notre-Dame (CHUM), Programme de gestion thérapeutique des médicaments; Jean-François Ouellet, MD, Hôtel-Dieu de Québec (CHU de Québec); Gilles Pineau, MD, INESSS; Raghu Rajan, MD, Montreal General Hospital (MUHC); Isabelle Roy, MD, Hôpital de la Cité-de-la-Santé (CSSS de Laval); Benoît Samson, Filion É, Rakovich G, Kopek N, Tremblay L, Samson B, Goulet S, Roy I

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2015 Jun; Vol. 10 (6), pp. 872-82.